On the public citation graph
Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
0 signed · 448 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.291.9.1092openalex-snapshot
Effect of Neurolytic Celiac Plexus Block on Pain Relief, Quality of Life, and Survival in Patients With Unresectable Pancreatic Cancer
inferredcites →https://doi.org/10.1002/cncr.24059openalex-snapshot
Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas
inferredcites →https://doi.org/10.1002/cncr.26365openalex-snapshot
Cost‐effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer
inferredcites →https://doi.org/10.1002/cncr.29161openalex-snapshot
Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma
inferredcites →https://doi.org/10.1007/s00508-013-0453-9openalex-snapshot
Evaluation of the effect of comorbidity on survival in pancreatic cancer by using “Charlson Comorbidity Index” and “Cumulative Illness Rating Scale”
inferredcites →https://doi.org/10.1007/s11605-007-0296-7openalex-snapshot
Neoadjuvant Chemotherapy and Radiation for Patients with Locally Unresectable Pancreatic Adenocarcinoma: Feasibility, Efficacy, and Survival
inferredcites →https://doi.org/10.1007/s12029-014-9668-xopenalex-snapshot
Pancreatic Cancer in the USA: Persistence of Undertreatment and Poor Outcome
inferredcites →https://doi.org/10.1016/j.ejca.2011.10.017openalex-snapshot
Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer
inferredcites →https://doi.org/10.1016/j.ijrobp.2003.11.004openalex-snapshot
Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer
inferredcites →https://doi.org/10.1016/j.ijrobp.2004.12.074openalex-snapshot
A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282
inferredcites →https://doi.org/10.1016/j.ijrobp.2006.07.1390openalex-snapshot
Using economic analysis to evaluate the potential of multimodality therapy for elderly patients with locally advanced pancreatic cancer
inferredcites →https://doi.org/10.1016/j.ijrobp.2008.01.051openalex-snapshot
Gemcitabine Chemotherapy and Single-Fraction Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer
inferredcites →https://doi.org/10.1016/j.ijrobp.2009.08.046openalex-snapshot
Stereotactic Body Radiotherapy and Gemcitabine for Locally Advanced Pancreatic Cancer
inferredcites →https://doi.org/10.1016/j.ijrobp.2010.05.006openalex-snapshot
Single-Fraction Stereotactic Body Radiation Therapy and Sequential Gemcitabine for the Treatment of Locally Advanced Pancreatic Cancer
inferredcites →https://doi.org/10.1016/j.ijrobp.2011.04.045openalex-snapshot
Induction Gemcitabine and Stereotactic Body Radiotherapy for Locally Advanced Nonmetastatic Pancreas Cancer
inferredcites →https://doi.org/10.1016/j.ijrobp.2015.07.884openalex-snapshot
Stereotactic Body Radiation for Pancreatic Cancer: Results of an International Survey of Practice Patterns
inferredcites →https://doi.org/10.1016/j.ijrobp.2015.08.026openalex-snapshot
Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic Cancer
inferredcites →https://doi.org/10.1016/j.jpainsymman.2014.01.015openalex-snapshot
Neurolytic Sympathectomy in the Management of Cancer Pain—Time Effect: A Prospective, Randomized Multicenter Study
inferredcites →https://doi.org/10.1016/j.radonc.2004.12.022openalex-snapshot
Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma
inferredcites →https://doi.org/10.1016/j.radonc.2011.04.001openalex-snapshot
Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: A meta-analysis
inferredcites →https://doi.org/10.1016/j.radonc.2011.05.038openalex-snapshot
Long-term results of full-dose gemcitabine with radiation therapy compared to 5-fluorouracil with radiation therapy for locally advanced pancreas cancer
inferredcites →https://doi.org/10.1016/j.soc.2012.12.003openalex-snapshot
Multidisciplinary Management of Pancreatic Cancer
inferredcites →https://doi.org/10.1016/j.thromres.2009.12.023openalex-snapshot
Venous thromboembolism and prognosis in cancer
inferredcites →https://doi.org/10.1016/s0360-3016(03)00435-8openalex-snapshot
Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: Gemcitabine versus 5-fluorouracil, a randomized controlled study
inferredcites →https://doi.org/10.1016/s1470-2045(13)70021-4openalex-snapshot
Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial
inferredcites →https://doi.org/10.1037/e481972008-001openalex-snapshot
Patient-centered communication in cancer care: Promoting healing and reducing suffering
inferredcites →https://doi.org/10.1038/sj.bjc.6603301openalex-snapshot
A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer
inferredcites →https://doi.org/10.1056/nejmoa1011923openalex-snapshot
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
inferredcites →https://doi.org/10.1056/nejmoa1304369openalex-snapshot
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
inferredcites →https://doi.org/10.1093/annonc/mdn281openalex-snapshot
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study
inferredcites →https://doi.org/10.1093/annonc/mds135openalex-snapshot
BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer
inferredcites →https://doi.org/10.1093/jnci/dju336openalex-snapshot
Generalizability of Trial Results to Elderly Medicare Patients With Advanced Solid Tumors (Alliance 70802)
inferredcites →https://doi.org/10.1097/00006676-200404000-00023openalex-snapshot
Phase III Trial of Radiosensitizer PR-350 Combined With Intraoperative Radiotherapy for the Treatment of Locally Advanced Pancreatic Cancer
inferredcites →https://doi.org/10.1097/cad.0b013e32833123edopenalex-snapshot
Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the ‘Arbeitsgemeinschaft Internistische Onkologie’
inferredcites →https://doi.org/10.1097/coc.0b013e3181d270b4openalex-snapshot
Stereotactic Body Radiotherapy in the Treatment of Advanced Adenocarcinoma of the Pancreas
inferredcites →https://doi.org/10.1097/sla.0000000000000226openalex-snapshot
Geriatric Assessment Improves Prediction of Surgical Outcomes in Older Adults Undergoing Pancreaticoduodenectomy
inferredcites →https://doi.org/10.1097/sla.0000000000001156openalex-snapshot
Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing
inferredcites →https://doi.org/10.1111/j.1538-7836.2007.02374.xopenalex-snapshot
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
inferredcites →https://doi.org/10.1111/j.1572-0241.2006.00559.xopenalex-snapshot
Long-term Outcome of Biliary and Duodenal Stents in Palliative Treatment of Patients with Unresectable Adenocarcinoma of the Head of Pancreas
inferredcites →https://doi.org/10.1136/amiajnl-2011-000172openalex-snapshot
Building better guidelines with BRIDGE-Wiz: development and evaluation of a software assistant to promote clarity, transparency, and implementability
inferredcites →https://doi.org/10.1136/gut.42.1.92openalex-snapshot
Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region
inferredcites →https://doi.org/10.1136/gutjnl-2012-302759openalex-snapshot
Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the ‘Arbeitsgemeinschaft Internistische Onkologie’ (AIO-PK0104)
inferredcites →https://doi.org/10.1158/0008-5472.can-14-0155openalex-snapshot
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
inferredcites →https://doi.org/10.1158/1078-0432.ccr-06-2351openalex-snapshot
Tissue Factor Expression, Angiogenesis, and Thrombosis in Pancreatic Cancer
inferredcites →https://doi.org/10.1161/01.cir.0000157738.12783.71openalex-snapshot
Racial and Ethnic Disparities in Care
inferredcites →https://doi.org/10.1177/082585970301900407openalex-snapshot
Pain Relief with Short Term Irradiation in Locally Advanced Carcinoma of the Pancreas
inferredcites →https://doi.org/10.1186/1471-2407-14-728openalex-snapshot
Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study
inferredcites →https://doi.org/10.1200/jco.1997.15.6.2403openalex-snapshot
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
inferredcites →https://doi.org/10.1200/jco.2002.09.029openalex-snapshot
Multicenter Randomized Phase III Trial Comparing Protracted Venous Infusion (PVI) Fluorouracil (5-FU) With PVI 5-FU Plus Mitomycin in Inoperable Pancreatic Cancer
inferredcites →https://doi.org/10.1200/jco.2002.11.149openalex-snapshot
Phase III Study of Gemcitabine in Combination With Fluorouracil Versus Gemcitabine Alone in Patients With Advanced Pancreatic Carcinoma: Eastern Cooperative Oncology Group Trial E2297
inferredcites →https://doi.org/10.1200/jco.2003.03.007openalex-snapshot
Treatment of Locally Advanced Pancreatic Cancer in the Real World: Population-Based Practices and Effectiveness
inferredcites →https://doi.org/10.1200/jco.2004.12.082openalex-snapshot
Irinotecan Plus Gemcitabine Results in No Survival Advantage Compared With Gemcitabine Monotherapy in Patients With Locally Advanced or Metastatic Pancreatic Cancer Despite Increased Tumor Response Rate
inferredcites →https://doi.org/10.1200/jco.2005.05.1490openalex-snapshot
Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer
inferredcites →https://doi.org/10.1200/jco.2006.09.0886openalex-snapshot
Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
inferredcites →https://doi.org/10.1200/jco.2007.15.6240openalex-snapshot
Clinical Benefit and Quality of Life in Patients With Advanced Pancreatic Cancer Receiving Gemcitabine Plus Capecitabine Versus Gemcitabine Alone: A Randomized Multicenter Phase III Clinical Trial—SAKK 44/00–CECOG/PAN.1.3.001
inferredcites →https://doi.org/10.1200/jco.2008.17.7188openalex-snapshot
DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
inferredcites →https://doi.org/10.1200/jco.2009.24.2446openalex-snapshot
Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
inferredcites →https://doi.org/10.1200/jco.2009.25.4433openalex-snapshot
Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study
inferredcites →https://doi.org/10.1200/jco.2009.25.7550openalex-snapshot
Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205
inferredcites →https://doi.org/10.1200/jco.2010.28.1386openalex-snapshot
Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
inferredcites →https://doi.org/10.1200/jco.2010.33.8038openalex-snapshot
Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With Pattern of Disease Progression
inferredcites →https://doi.org/10.1200/jco.2011.29.15_suppl.9059openalex-snapshot
Incidence and risk factors predictive of recurrent venous thromboembolism in patients with cancer at a comprehensive cancer center.
inferredcites →https://doi.org/10.1200/jco.2011.34.8904openalex-snapshot
Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial
inferredcites →https://doi.org/10.1200/jco.2012.43.3680openalex-snapshot
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
inferredcites →https://doi.org/10.1200/jco.2012.44.4869openalex-snapshot
Impact of FOLFIRINOX Compared With Gemcitabine on Quality of Life in Patients With Metastatic Pancreatic Cancer: Results From the PRODIGE 4/ACCORD 11 Randomized Trial
inferredcites →https://doi.org/10.1200/jco.2012.44.7516openalex-snapshot
Randomized Phase III Multi-Institutional Study of TNFerade Biologic With Fluorouracil and Radiotherapy for Locally Advanced Pancreatic Cancer: Final Results
inferredcites →https://doi.org/10.1200/jco.2014.59.7351openalex-snapshot
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
inferredcites →https://doi.org/10.1245/s10434-008-9929-7openalex-snapshot
Evaluating the Impact of a Single-Day Multidisciplinary Clinic on the Management of Pancreatic Cancer
inferredcites →https://doi.org/10.1245/s10434-011-1693-4openalex-snapshot
Pancreas-Protocol Imaging at a High-Volume Center Leads to Improved Preoperative Staging of Pancreatic Ductal Adenocarcinoma
inferredcites →https://doi.org/10.1245/s10434-014-4274-5openalex-snapshot
The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience
inferredcites →https://doi.org/10.1371/journal.pmed.1000267openalex-snapshot
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
inferredcites →https://doi.org/10.3748/wjg.v20.i28.9345openalex-snapshot
Managing malignant biliary obstruction in pancreas cancer: choosing the appropriate strategy.
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4706360openalex-extracted
Standard or High Dose Chemoradiotherapy, with or Without the Protease Inhibitor Nelfinavir, for the Treatment of Locally Advanced Pancreatic Cancer: Efficacy, Safety and Health-Related Quality of Life Outcomes from the Multi-Centre Two Stage Phase 1/Randomised Phase 2 SCALOP-2 Study
inferred← citeshttps://doi.org/10.1001/jamasurg.2019.2277openalex-snapshot
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
inferred← citeshttps://doi.org/10.1002/9781119188421.ch118openalex-snapshot
Role of Radio and Proton Beam Therapy for Pancreatic Cancer
inferred← citeshttps://doi.org/10.1002/acm2.70427openalex-snapshot
Application of intrahepatic fiducial markers in carbon ion radiotherapy for pancreatic cancer—Achieving higher precision treatment
inferred← citeshttps://doi.org/10.1002/btm2.70028openalex-snapshot
Synergizing photodynamic therapy and ethanol ablation: Light‐activatable sustained‐exposure ethanol injection technology for enhanced tumor ablation
inferred← citeshttps://doi.org/10.1002/cam4.2705openalex-snapshot
Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis
inferred← citeshttps://doi.org/10.1002/cam4.3119openalex-snapshot
Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation
inferred← citeshttps://doi.org/10.1002/cam4.7434openalex-snapshot
Escalated‐dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United States
inferred← citeshttps://doi.org/10.1002/cbf.3920openalex-snapshot
Role of bio‐flavonols and their derivatives in improving mitochondrial dysfunctions associated with pancreatic tumorigenesis
inferred← citeshttps://doi.org/10.1002/ccr3.2429openalex-snapshot
Long‐term survival after surgery of pancreatic primary squamous cell carcinoma: A case report and literature review
inferred← citeshttps://doi.org/10.1002/ijc.31628openalex-snapshot
Nonsurgical therapies for resected and unresected pancreatic cancer in Europe and USA in 2003–2014: a large international population‐based study
inferred← citeshttps://doi.org/10.1002/ima.70040openalex-snapshot
Pancreatic Tumor Detection From CT Images Converted to Graphs Using Whale Optimization and Classification Algorithms With Transfer Learning
inferred← citeshttps://doi.org/10.1002/jso.25233openalex-snapshot
FOLFIRINOX and radiotherapy for locally advanced pancreatic cancer: A cohort study
inferred← citeshttps://doi.org/10.1002/jso.25968openalex-snapshot
The yield of chest computed tomography in patients with locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1002/jso.27085openalex-snapshot
Long‐term follow‐up experience with adjuvant therapy after irreversible electroporation of locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1002/jso.27851openalex-snapshot
Trends in the Care of Locally Advanced Pancreatic Cancer in the Modern Era of Chemotherapy
inferred← citeshttps://doi.org/10.1002/jum.14881openalex-snapshot
Bedside Neurolysis for Palliative Care of Critically Ill Patients With Pancreatic Cancer
inferred← citeshttps://doi.org/10.1002/mp.15692openalex-snapshot
Automatic stent recognition using perceptual attention U‐net for quantitative intrafraction motion monitoring in pancreatic cancer radiotherapy
inferred← citeshttps://doi.org/10.1002/smtd.202100402openalex-snapshot
Nanotechnology‐Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID‐19 Vaccines
inferred← citeshttps://doi.org/10.1002/ueg2.12744openalex-snapshot
Incidence and Management of Splanchnic Vein Thrombosis in Pancreatic Diseases
inferred← citeshttps://doi.org/10.1007/174_2017_97openalex-snapshot
Gastrointestinal Cancer: Pancreas
inferred← citeshttps://doi.org/10.1007/978-1-4939-6631-8_26-2openalex-snapshot
Clinical Decision-Making in Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4939-7193-0_26openalex-snapshot
Clinical Decision-Making in Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-31635-8_157openalex-snapshot
Comparison of Different Radiotherapy Techniques for Locally Advanced Pancreatic Tumors
inferred← citeshttps://doi.org/10.1007/978-3-030-38261-2_8openalex-snapshot
High-Field MRI In-Room Guidance for Radiotherapy Adaptation
inferred← citeshttps://doi.org/10.1007/978-3-030-47963-3_24openalex-snapshot
Hepatopancreaticobiliary Surgery in the Elderly
inferred← citeshttps://doi.org/10.1007/978-3-030-69940-6_6openalex-snapshot
Imaging Diagnostics in Pancreatic Cancer from the Perspective of an Oncologist
inferred← citeshttps://doi.org/10.1007/978-3-030-87308-0_10openalex-snapshot
Gastrointestinal System Cancers
inferred← citeshttps://doi.org/10.1007/978-3-031-05724-3_9openalex-snapshot
Management of Locally Advanced/Metastatic Disease: Medical Oncology
inferred← citeshttps://doi.org/10.1007/978-3-031-21351-9_13openalex-snapshot
Oncologic Adjuvant and Neoadjuvant Treatments in Pancreatic Adenocarcinoma
inferred← citeshttps://doi.org/10.1007/978-3-032-28601-7_28openalex-snapshot
Metastatic Pancreatic Cancer: Biology, Diagnosis, and Evolving Therapies
inferred← citeshttps://doi.org/10.1007/978-3-319-26779-1_286-1openalex-snapshot
Pancreatic and Adrenal Tumors: Current Therapeutic Approaches and the Emerging Role of Electroporation in Human and Veterinary Medicine
inferred← citeshttps://doi.org/10.1007/978-3-319-54301-7_20openalex-snapshot
Pancreatic Resection After Neoadjuvant Treatment
inferred← citeshttps://doi.org/10.1007/978-3-319-74698-2_180-2openalex-snapshot
Pancreatic Surgery in Cancer Patients
inferred← citeshttps://doi.org/10.1007/978-3-319-75856-5_19openalex-snapshot
Treatment of Pancreatic Diseases
inferred← citeshttps://doi.org/10.1007/978-3-319-97145-2_5openalex-snapshot
Gastrointestinal System Cancers
inferred← citeshttps://doi.org/10.1007/s00066-017-1227-5openalex-snapshot
Essential role of radiation therapy for the treatment of pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00108-018-0460-zopenalex-snapshot
Duktales Adenokarzinom des Pankreas
inferred← citeshttps://doi.org/10.1007/s00261-020-02661-wopenalex-snapshot
Prognostic factors in patients with locally advanced or borderline resectable pancreatic ductal adenocarcinoma: chemotherapy vs. chemoradiotherapy
inferred← citeshttps://doi.org/10.1007/s00280-017-3313-xopenalex-snapshot
Phase 1b study of galunisertib in combination with gemcitabine in Japanese patients with metastatic or locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00280-017-3477-4openalex-snapshot
Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma
inferred← citeshttps://doi.org/10.1007/s00423-021-02199-5openalex-snapshot
Laparoscopic biopsy and staging for locally advanced pancreatic cancer: experiences of 76 consecutive patients in a single institution
inferred← citeshttps://doi.org/10.1007/s00423-021-02321-7openalex-snapshot
Nab-paclitaxel plus S-1 with or without PD-1 inhibitor in pancreatic ductal adenocarcinoma with only hepatic metastases: a retrospective cohort study
inferred← citeshttps://doi.org/10.1007/s00432-025-06397-2openalex-snapshot
Neoadjuvant SBRT and intraoperative electron radiotherapy in pancreatic cancer resection
inferred← citeshttps://doi.org/10.1007/s00464-018-6217-xopenalex-snapshot
Technique, safety, and feasibility of EUS-guided radiofrequency ablation in unresectable pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00464-025-12333-9openalex-snapshot
Cost-effectiveness analysis of palliative treatment for periampullary cancer: a comparison of surgical and endoscopic approaches
inferred← citeshttps://doi.org/10.1007/s00520-023-07709-3openalex-snapshot
The impact of early palliative care on the quality of life of patients with advanced pancreatic cancer: The IMPERATIVE case-crossover study
inferred← citeshttps://doi.org/10.1007/s00740-020-00326-4openalex-snapshot
Rolle der Radiotherapie beim Pankreaskarzinom
inferred← citeshttps://doi.org/10.1007/s00761-019-0546-9openalex-snapshot
Rolle der Radiotherapie beim Pankreaskarzinom
inferred← citeshttps://doi.org/10.1007/s11377-019-0340-7openalex-snapshot
Duktales Adenokarzinom des Pankreas
inferred← citeshttps://doi.org/10.1007/s11864-017-0515-8openalex-snapshot
The Multidisciplinary Approach to Localized Pancreatic Adenocarcinoma
inferred← citeshttps://doi.org/10.1007/s11864-020-00801-4openalex-snapshot
Symptom Management in Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/s12029-017-0033-8openalex-snapshot
Identification of Educational Gaps Among Oncologists Who Manage Patients with Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/s12029-024-01153-0openalex-snapshot
The Association Between Patient-Reported Outcomes and Surgical Attrition During Neoadjuvant Therapy for Gastrointestinal Malignancies
inferred← citeshttps://doi.org/10.1007/s12029-025-01269-xopenalex-snapshot
Role of Neoadjuvant Therapy for Patients with Adenosquamous Carcinoma of the Pancreas: Outcomes from the National Cancer Database
inferred← citeshttps://doi.org/10.1007/s12094-016-1586-xopenalex-snapshot
SEOM Clinical Guideline for the treatment of pancreatic cancer (2016)
inferred← citeshttps://doi.org/10.1007/s12094-020-02350-6openalex-snapshot
Multidisciplinary consensus statement on the clinical management of patients with pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s12672-026-05481-4openalex-snapshot
Toxicity outcomes of concurrent radiotherapy with adjuvant capecitabine in triple-negative breast cancer (TROD 06-24)
inferred← citeshttps://doi.org/10.1007/s13402-019-00473-9openalex-snapshot
Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells
inferred← citeshttps://doi.org/10.1007/s13566-016-0267-2openalex-snapshot
Stereotactic body radiation for pancreatic cancer: results of an international survey of practice patterns
inferred← citeshttps://doi.org/10.1007/s40137-023-00370-zopenalex-snapshot
Current Approaches to the Management of Locally Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-12-819547-5.00046-8openalex-snapshot
Pharmacological ascorbate and use in pancreatic cancer
inferred← citeshttps://doi.org/10.1016/b978-0-323-87688-9.00024-6openalex-snapshot
Palliative radiotherapy for gastrointestinal malignancies
inferred← citeshttps://doi.org/10.1016/b978-0-443-19142-8.00008-5openalex-snapshot
Clinical practice guidelines for interventional treatment of pancreatic cancer
inferred← citeshttps://doi.org/10.1016/j.adro.2021.100650openalex-snapshot
Quantifying and Assessing the Dosimetric Impact of Changing Gas Volumes Throughout the Course of VMAT Radiation Therapy of Upper Gastrointestinal Tumors
inferred← citeshttps://doi.org/10.1016/j.adro.2021.100763openalex-snapshot
Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era
inferred← citeshttps://doi.org/10.1016/j.adro.2022.101164openalex-snapshot
Dose Escalation for Pancreas SBRT: Potential and Limitations of using Daily Online Adaptive Radiation Therapy and an Iterative Isotoxicity Automated Planning Approach
inferred← citeshttps://doi.org/10.1016/j.adro.2023.101250openalex-snapshot
Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer: Results From a Multi-Institutional Prospective Registry
inferred← citeshttps://doi.org/10.1016/j.canrad.2018.06.005openalex-snapshot
Quelle place pour la radiothérapie dans la prise en charge des cancers du pancréas localisés ?
inferred← citeshttps://doi.org/10.1016/j.canrad.2020.08.047openalex-snapshot
Radiothérapie stéréotaxique dans le cancer du pancréas localement avancé : revue de la littérature
inferred← citeshttps://doi.org/10.1016/j.ccell.2020.02.008openalex-snapshot
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/j.cireng.2021.11.001openalex-snapshot
Implementation of a regional reference center in pancreatic surgery. Experience after 631 procedures
inferred← citeshttps://doi.org/10.1016/j.ciresp.2020.09.013openalex-snapshot
Implementación de un centro de referencia regional en cirugía pancreática. Experiencia tras 631 procedimientos
inferred← citeshttps://doi.org/10.1016/j.clbc.2020.02.010openalex-snapshot
Combining Adjuvant Radiotherapy With Capecitabine in Chemotherapy-resistant Breast Cancer: Feasibility, Safety, and Toxicity
inferred← citeshttps://doi.org/10.1016/j.clon.2017.01.038openalex-snapshot
Correlation of 18F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in Locally Advanced Pancreatic Cancer after Definitive Chemoradiotherapy
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2021.103571openalex-snapshot
Evolving pancreatic cancer treatment: From diagnosis to healthcare management
inferred← citeshttps://doi.org/10.1016/j.ctarc.2025.101036openalex-snapshot
Oxaliplatin and/or gemcitabine vs. FOLFIRINOX in first-line Advanced pancreatic adenocarcinoma: Real-world efficacy and safety data of moroccan patients
inferred← citeshttps://doi.org/10.1016/j.ctro.2021.04.002openalex-snapshot
The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change?
inferred← citeshttps://doi.org/10.1016/j.ctro.2025.101081openalex-snapshot
Evaluation of loco-regional recurrences using deformable image registration after isotoxic high dose stereotactic body radiotherapy in localised pancreatic cancer
inferred← citeshttps://doi.org/10.1016/j.ctrv.2018.06.006openalex-snapshot
Borderline resectable pancreatic cancer. Challenges and controversies
inferred← citeshttps://doi.org/10.1016/j.ctrv.2019.05.007openalex-snapshot
Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidence
inferred← citeshttps://doi.org/10.1016/j.currproblcancer.2017.10.006openalex-snapshot
Locally advanced pancreatic cancer: An emerging entity
inferred← citeshttps://doi.org/10.1016/j.currproblcancer.2017.12.003openalex-snapshot
Emerging facets in the treatment of patients with hepatopancreaticobiliary malignancies
inferred← citeshttps://doi.org/10.1016/j.diii.2019.11.001openalex-snapshot
18F-FDG PET/CT in pancreatic adenocarcinoma: On the edge of a paradigm shift?
inferred← citeshttps://doi.org/10.1016/j.dld.2016.11.010openalex-snapshot
Borderline resectable pancreatic cancer: More than an anatomical concept
inferred← citeshttps://doi.org/10.1016/j.dld.2019.03.004openalex-snapshot
FOLFIRINOX-based neoadjuvant chemoradiotherapy for borderline and locally advanced pancreatic cancer: A pilot study from a tertiary centre
inferred← citeshttps://doi.org/10.1016/j.eclinm.2019.10.013openalex-snapshot
Efficacy and feasibility of stereotactic radiotherapy after folfirinox in patients with locally advanced pancreatic cancer (LAPC-1 trial)
inferred← citeshttps://doi.org/10.1016/j.ejca.2017.03.022openalex-snapshot
3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer
inferred← citeshttps://doi.org/10.1016/j.ejca.2019.10.023openalex-snapshot
A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study
inferred← citeshttps://doi.org/10.1016/j.ejca.2021.02.023openalex-snapshot
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer – A GISCAD phase II randomized trial
inferred← citeshttps://doi.org/10.1016/j.ejca.2021.05.034openalex-snapshot
Efficacy of systemic oncological treatments in patients with advanced pancreatic cancer at high risk of dying in the short or medium-term: overview of systematic reviews
inferred← citeshttps://doi.org/10.1016/j.ejca.2024.114236openalex-snapshot
Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial
inferred← citeshttps://doi.org/10.1016/j.ejso.2018.07.047openalex-snapshot
Irreversible Electroporation in pancreatic ductal adenocarcinoma: Is there a role in conjunction with conventional treatment?
inferred← citeshttps://doi.org/10.1016/j.ejso.2019.06.004openalex-snapshot
Yield of staging laparoscopy before treatment of locally advanced pancreatic cancer to detect occult metastases
inferred← citeshttps://doi.org/10.1016/j.ejso.2019.12.006openalex-snapshot
Prognostic factor analysis of irreversible electroporation for locally advanced pancreatic cancer – A multi-institutional clinical study in Asia
inferred← citeshttps://doi.org/10.1016/j.ejso.2020.05.017openalex-snapshot
The efficacy and safety of the open approach irreversible electroporation in the treatment of pancreatic cancer: A systematic review
inferred← citeshttps://doi.org/10.1016/j.ejso.2026.111908openalex-snapshot
Impact of cytoreductive surgery with HIPEC in the treatment of pancreatic cancer with peritoneal carcinomatosis: A systematic review
inferred← citeshttps://doi.org/10.1016/j.esmoop.2021.100356openalex-snapshot
Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy
inferred← citeshttps://doi.org/10.1016/j.gassur.2024.101882openalex-snapshot
Value of radiomics features extracted from baseline computed tomography images in predicting overall survival in patients with nonsurgical pancreatic ductal adenocarcinoma: incorporation of a radiomics score to a multiparametric nomogram to predict 1-year overall survival
inferred← citeshttps://doi.org/10.1016/j.gie.2020.02.012openalex-snapshot
Tolerability and safety of EUS-injected adenovirus-mediated double-suicide gene therapy with chemotherapy in locally advanced pancreatic cancer: a phase 1 trial
inferred← citeshttps://doi.org/10.1016/j.gie.2025.04.054openalex-snapshot
Combined phosphorus-32 implantation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer: a propensity score–weighted landmark analysis
inferred← citeshttps://doi.org/10.1016/j.giec.2023.03.002openalex-snapshot
Are All Cysts Created Equal?
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e38196openalex-snapshot
The road to overcome pancreatic cancer: Where are we?
inferred← citeshttps://doi.org/10.1016/j.heliyon.2026.e45191openalex-snapshot
Efficacy, safety, and quality-of-life improvement of chemotherapy regimens for treatment of unresectable pancreatic cancer: a systematic review and network meta-analysis of phase III randomised controlled trials
inferred← citeshttps://doi.org/10.1016/j.hpb.2018.08.016openalex-snapshot
Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus
inferred← citeshttps://doi.org/10.1016/j.hpb.2020.09.022openalex-snapshot
Survival equivalence in patients treated for borderline resectable and unresectable locally advanced pancreatic ductal adenocarcinoma: a systematic review and network meta-analysis
inferred← citeshttps://doi.org/10.1016/j.humpath.2018.01.009openalex-snapshot
The absence of class III β-tubulin is predictive of a favorable response to nab-paclitaxel and gemcitabine in patients with unresectable pancreatic ductal adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2015.07.884openalex-snapshot
Stereotactic Body Radiation for Pancreatic Cancer: Results of an International Survey of Practice Patterns
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2016.10.030openalex-snapshot
Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer: A Systematic Review and Pooled Analysis of 19 Trials
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2018.04.057openalex-snapshot
Multi-institutional Study of Carbon-ion Radiotherapy for Locally Advanced Pancreatic Cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1403 Pancreas
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2020.11.017openalex-snapshot
Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2025.09.013openalex-snapshot
Improving Radiation Therapy in Pancreatic Cancer Through Radiosensitization Strategies
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2026.09.005openalex-snapshot
Concurrent Systemic Therapy Intensity and Metabolic Response in Carbon-Ion Radiation Therapy for Locally Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/j.ijsu.2019.09.014openalex-snapshot
Intraductal papillary mucinous carcinoma versus pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.imr.2023.100921openalex-snapshot
Complementary and alternative medicine mention and recommendations in pancreatic cancer clinical practice guidelines: A systematic review and quality assessment
inferred← citeshttps://doi.org/10.1016/j.inpm.2025.100633openalex-snapshot
Assessing the availability, readability, and content of online patient Education materials for cancer pain interventions: A cross-sectional analysis of major cancer center websites
inferred← citeshttps://doi.org/10.1016/j.jconrel.2024.08.020openalex-snapshot
Lipiodol emulsion as a dual chemoradiation-sensitizer for pancreatic cancer treatment
inferred← citeshttps://doi.org/10.1016/j.jcrpr.2017.10.001openalex-snapshot
Cure of unresectable, locally advanced pancreatic cancer after multidisciplinary therapy
inferred← citeshttps://doi.org/10.1016/j.jpainsymman.2020.01.007openalex-snapshot
A Randomized, Placebo-Controlled, Double-Blind Study of Minocycline for Reducing the Symptom Burden Experienced by Patients With Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/j.jpainsymman.2021.01.122openalex-snapshot
Quality Indicators in Surgical Palliative Care: A Systematic Review
inferred← citeshttps://doi.org/10.1016/j.jss.2019.12.036openalex-snapshot
Pancreatic Adenocarcinoma Causing Necrotizing Pancreatitis: Not as Rare as You Think?
inferred← citeshttps://doi.org/10.1016/j.med.2017.04.013openalex-snapshot
Actualización en cáncer de páncreas y de vías biliares
inferred← citeshttps://doi.org/10.1016/j.mpdhp.2018.08.007openalex-snapshot
Pancreaticobiliary cytopathology: an update
inferred← citeshttps://doi.org/10.1016/j.mtbio.2026.103014openalex-snapshot
Stromal homeostasis-restoring “rocket-like” nanomedicine inhibited pancreatic tumor growth in vivo
inferred← citeshttps://doi.org/10.1016/j.nantod.2022.101490openalex-snapshot
Nanodrug simultaneously regulates stromal extracellular matrix and glucose metabolism for effective immunotherapy against orthotopic pancreatic cancer
inferred← citeshttps://doi.org/10.1016/j.pan.2017.07.191openalex-snapshot
Comparison of proton beam radiotherapy and hyper-fractionated accelerated chemoradiotherapy for locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1016/j.pan.2021.08.002openalex-snapshot
Open irreversible electroporation for isolated local recurrence of pancreatic ductal adenocarcinoma after primary surgery
inferred← citeshttps://doi.org/10.1016/j.pan.2022.01.004openalex-snapshot
Identifying optimal candidates for tumor resection among borderline and locally advanced pancreatic cancer: A population-based predictive model
inferred← citeshttps://doi.org/10.1016/j.pan.2024.07.006openalex-snapshot
Early tumor shrinkage as a prognostic predictor in chemotherapy-naïve patients with locally advanced pancreatic cancer treated with modified FOLFIRINOX or gemcitabine plus nab-paclitaxel combination therapy: An exploratory analysis of JCOG1407
inferred← citeshttps://doi.org/10.1016/j.pop.2017.07.004openalex-snapshot
Pancreatitis and Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/j.prro.2019.01.008openalex-snapshot
Recognition of Tumor Invasion of a Pancreatic Head Biliary Stent During Stereotactic Body Radiation Therapy
inferred← citeshttps://doi.org/10.1016/j.prro.2019.06.016openalex-snapshot
Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline
inferred← citeshttps://doi.org/10.1016/j.prro.2019.10.012openalex-snapshot
Setup Management for Stereotactic Body Radiation Therapy of Patients With Pancreatic Cancer Treated via the Breath-Hold Technique
inferred← citeshttps://doi.org/10.1016/j.radonc.2018.08.012openalex-snapshot
Prediction of overall survival after re-irradiation with stereotactic body radiation therapy for pancreatic cancer with a novel prognostic model (the SCAD score)
inferred← citeshttps://doi.org/10.1016/j.radonc.2020.04.010openalex-snapshot
Recommendations for the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19
inferred← citeshttps://doi.org/10.1016/j.radonc.2020.07.053openalex-snapshot
Intensified systemic therapy and stereotactic ablative radiotherapy dose for patients with unresectable pancreatic adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.radonc.2020.11.006openalex-snapshot
A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): Long-term outcome
inferred← citeshttps://doi.org/10.1016/j.radonc.2021.07.009openalex-snapshot
Stereotactic body radiation therapy with sequential S-1 for patients with locally advanced pancreatic cancer and poor performance status: An open-label, single-arm, phase 2 trial
inferred← citeshttps://doi.org/10.1016/j.redox.2022.102505openalex-snapshot
Cystathionine β-synthase overexpression drives metastatic dissemination in pancreatic ductal adenocarcinoma via inducing epithelial-to-mesenchymal transformation of cancer cells
inferred← citeshttps://doi.org/10.1016/j.semradonc.2017.02.005openalex-snapshot
Integration of Stereotactic Body Radiation Therapy into the Multidisciplinary Management of Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/j.soi.2024.100075openalex-snapshot
Impact of irreversible electroporation on survival among patients with borderline resectable/locally advanced pancreatic cancer: A single center experience
inferred← citeshttps://doi.org/10.1016/j.suc.2017.09.006openalex-snapshot
Timing of Pancreatic Resection and Patient Outcomes
inferred← citeshttps://doi.org/10.1016/j.suc.2017.09.008openalex-snapshot
The Evolving Role of Radiation in Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/j.suc.2024.04.008openalex-snapshot
Surgical Palliation for Advanced Pancreas Cancer
inferred← citeshttps://doi.org/10.1016/j.surg.2017.09.012openalex-snapshot
Locally advanced pancreas cancer: Staging and goals of therapy
inferred← citeshttps://doi.org/10.1016/j.suronc.2021.101542openalex-snapshot
Survival impact on triple-modal strategy comprising hyperthermia, external radiation, and chemotherapy for unresectable locally advanced (UR-LA) pancreatic ductal adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.tranon.2018.02.023openalex-snapshot
Chemotherapy and Radiofrequency-Induced Mild Hyperthermia Combined Treatment of Orthotopic Pancreatic Ductal Adenocarcinoma Xenografts
inferred← citeshttps://doi.org/10.1016/j.tranon.2025.102632openalex-snapshot
Radiotherapy in the management of PDAC, from past to present
inferred← citeshttps://doi.org/10.1016/j.ultrasmedbio.2023.06.003openalex-snapshot
Evaluation of Tumor Fibrosis in Pancreatic Ductal Adenocarcinoma by 2-D Shear Wave Elastography: A Pilot Study
inferred← citeshttps://doi.org/10.1016/s2468-1253(19)30327-9openalex-snapshot
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study
inferred← citeshttps://doi.org/10.1016/s2468-1253(19)30404-2openalex-snapshot
Charging forward in locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1016/s2468-1253(20)30330-7openalex-snapshot
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
inferred← citeshttps://doi.org/10.1021/acsami.5c25021openalex-snapshot
Dual-Targeting iRGD-Functionalized Pentablock Copolymer Nanosystem for miR-345-5p and Gemcitabine Delivery to Pancreatic Tumors
inferred← citeshttps://doi.org/10.1038/ajg.2018.14openalex-snapshot
ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts
inferred← citeshttps://doi.org/10.1038/nrclinonc.2016.127openalex-snapshot
Clinical practice guidelines — what is the evidence?
inferred← citeshttps://doi.org/10.1038/s41392-020-00260-1openalex-snapshot
Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients
inferred← citeshttps://doi.org/10.1038/s41416-018-0140-8openalex-snapshot
Characteristics of The Cancer Genome Atlas cases relative to U.S. general population cancer cases
inferred← citeshttps://doi.org/10.1038/s41416-021-01649-7openalex-snapshot
A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study
inferred← citeshttps://doi.org/10.1038/s41419-022-04573-7openalex-snapshot
The anthelmintic drug niclosamide induces GSK-β-mediated β-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression
inferred← citeshttps://doi.org/10.1038/s41467-018-05906-xopenalex-snapshot
Reversal of pancreatic desmoplasia by re-educating stellate cells with a tumour microenvironment-activated nanosystem
inferred← citeshttps://doi.org/10.1038/s41467-020-17672-wopenalex-snapshot
An optimal posttreatment surveillance strategy for cancer survivors based on an individualized risk-based approach
inferred← citeshttps://doi.org/10.1038/s41575-023-00856-2openalex-snapshot
Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1038/s41598-017-12670-3openalex-snapshot
Synergistic effect of a drug loaded electrospun patch and systemic chemotherapy in pancreatic cancer xenograft
inferred← citeshttps://doi.org/10.1038/s41598-019-52486-xopenalex-snapshot
Gemcitabine plus nab-paclitaxel for locally advanced or borderline resectable pancreatic cancer
inferred← citeshttps://doi.org/10.1038/s41598-019-56268-3openalex-snapshot
Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1038/s41598-020-64421-6openalex-snapshot
The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort
inferred← citeshttps://doi.org/10.1038/s41598-023-34827-zopenalex-snapshot
Combinatorial immunotherapy with gemcitabine and ex vivo-expanded NK cells induces anti-tumor effects in pancreatic cancer
inferred← citeshttps://doi.org/10.1038/s41598-023-36886-8openalex-snapshot
Diagnostic ability of deep learning in detection of pancreatic tumour
inferred← citeshttps://doi.org/10.1053/j.seminoncol.2018.12.004openalex-snapshot
Selecting chemotherapy for pancreatic cancer: Far away or so close?
inferred← citeshttps://doi.org/10.1055/a-1856-7346openalex-snapshot
S3-Leitlinie zum exokrinen Pankreaskarzinom – Langversion 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL
inferred← citeshttps://doi.org/10.1055/a-2338-3533openalex-snapshot
S3-Leitlinie Exokrines Pankreaskarzinom – Version 3.1
inferred← citeshttps://doi.org/10.1055/s-0045-1811946openalex-snapshot
Indian Consensus Guidelines for the Management of Pancreatic Cancer
inferred← citeshttps://doi.org/10.1080/00365521.2017.1346705openalex-snapshot
The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer: a systematic review of safety and efficacy
inferred← citeshttps://doi.org/10.1080/02656736.2020.1798514openalex-snapshot
Magnetic nanoparticle hyperthermia for treating locally advanced unresectable and borderline resectable pancreatic cancers: the role of tumor size and eddy-current heating
inferred← citeshttps://doi.org/10.1080/14656566.2022.2149322openalex-snapshot
Pharmacotherapeutic options for pancreatic ductal adenocarcinoma
inferred← citeshttps://doi.org/10.1080/21645515.2017.1359362openalex-snapshot
Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers
inferred← citeshttps://doi.org/10.1080/21645515.2018.1524238openalex-snapshot
Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines
inferred← citeshttps://doi.org/10.1089/jpm.2025.0037openalex-snapshot
Pancreatic Enzyme Supplementation for Patients with Pancreatic Cancer #500
inferred← citeshttps://doi.org/10.1093/bjr/tqag198openalex-snapshot
Stereotactic body radiation therapy for pancreatic cancer: evaluating its efficacy, safety, and future prospects: systematic review
inferred← citeshttps://doi.org/10.1093/bjs/znae033openalex-snapshot
Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study
inferred← citeshttps://doi.org/10.1093/nop/npae052openalex-snapshot
Identifying research priorities and essential elements of palliative care services for people facing malignant brain tumors: A participatory co-design approach
inferred← citeshttps://doi.org/10.1093/oncolo/oyac002openalex-snapshot
N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic Adenocarcinoma
inferred← citeshttps://doi.org/10.1097/aia.0000000000000503openalex-snapshot
Procedural Interventions for the Treatment of Cancer Pain
inferred← citeshttps://doi.org/10.1097/coc.0000000000000802openalex-snapshot
Early Palliative Care Is Associated With Reduced Emergency Department Utilization in Pancreatic Cancer
inferred← citeshttps://doi.org/10.1097/eus.0000000000000174openalex-snapshot
Comparison of postprocedural adverse events between same-day and separate-day combined EUS-guided fine-needle aspiration/biopsy and endoscopic retrograde cholangiopancreatography in patients with pancreatic mass and biliary obstruction: A retrospective cohort study
inferred← citeshttps://doi.org/10.1097/js9.0000000000001389openalex-snapshot
Metabolic tumor burden as a prognostic indicator after neoadjuvant chemotherapy in pancreatic cancer
inferred← citeshttps://doi.org/10.1097/md.0000000000015064openalex-snapshot
Prognostic values of 18F-FDG PET/CT metabolic parameters and clinical figures in locally advanced pancreatic cancer underwent chemotherapy combined with stereotactic body radiation therapy
inferred← citeshttps://doi.org/10.1097/md.0000000000026052openalex-snapshot
A phase II study of gemcitabine plus nab-paclitaxel as first-line therapy for locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1097/mnm.0000000000000855openalex-snapshot
Clinical impact of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in patients with resectable pancreatic cancer
inferred← citeshttps://doi.org/10.1097/mpa.0000000000000897openalex-snapshot
Pancreatic Cancer Arising From the Remnant Pancreas
inferred← citeshttps://doi.org/10.1097/mpa.0000000000001049openalex-snapshot
Nationwide Multicenter Observational Study of FOLFIRINOX Chemotherapy in 399 Patients With Unresectable or Recurrent Pancreatic Cancer in Japan
inferred← citeshttps://doi.org/10.1097/mpa.0000000000001584openalex-snapshot
Radiation as a Single-Modality Treatment in Localized Pancreatic Cancer
inferred← citeshttps://doi.org/10.1097/mpa.0000000000001964openalex-snapshot
Verification of Resectability Status for Pancreatic Cancer
inferred← citeshttps://doi.org/10.1097/mpa.0000000000002032openalex-snapshot
Class III β-Tubulin Expression Is of Value in Selecting nab-Paclitaxel and Gemcitabine as First-Line Therapy in Unresectable Pancreatic Cancer
inferred← citeshttps://doi.org/10.1097/mpa.0000000000002065openalex-snapshot
Phase I Trial of nab-Paclitaxel Administered Concurrently With Radiotherapy in Patients With Locally Advanced Inoperable Pancreatic Adenocarcinoma
showing the first 200 of 376 · page through all 376
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.